Researchers from the National University of Singapore (NUS) have demonstrated an innovative approach for targeted breast...
Ascletis Pharma has initiated a US Phase I clinical study of ASC36 oral tablets, an investigational amylin receptor pept...
Kelun-Biotech has reported positive interim Phase II results for SKB378/WIN378, an investigational ultra-long-acting mon...
Alebund Pharmaceuticals has received clearance from the US Food and Drug Administration for the Investigational New Drug...
For children born with cleft lip and palate, repairing gaps in the jawbone often means waiting until they are 10 to 12 y...
Singapore has spent decades building the foundations of a global biomedical hub. The more difficult task now is not to s...
Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and ...
Scientists from Nanyang Technological University (NTU), Singapore have developed microscopic peptide droplets that deliv...
South Korea based Alteogen Inc. has entered into an option and license agreement with Novartis for the development and c...
Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a...
Before we discuss the market, can you tell us about your role and what drew you to this area of healthcare logistics? I...
Osivax, a France based clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to...
Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensin...
Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-gene...
CanSino Biologics reported continued momentum in its international business during the first half of 2026, alongside pro...
Antengene has received approval in Australia to initiate a Phase I clinical study of ATG-201, its investigational CD19/C...
Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced ...
AUScelerate and the Shanghai Center of Biomedicine Development have signed a Memorandum of Understanding (MoU) to build ...
Biopharmaceutical manufacturing is entering a period of significant change. With over 2000 biological therapeutics in de...
How will the new investment accelerate the development of TAVST01? When do you plan to launch the product in the market?...
US-based Celularity Inc., a longevity-focused regenerative and cellular medicine company, and Singaporean startup M...
The World Health Organization (WHO) has designated the Global Harmonisation Centre (GHC) in the Republic of Korea as a...
Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, a first-in-human study evaluat...
Japan-based Shimadzu Corporation has invested in OptQC Inc., a startup originating from The University of Tokyo, through...
A mobile clinic has been launched as part of an initiative of The University of Queensland (UQ) and the Australian Cance...
